Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new look at proliferation.

G D Wilson1

  • 1Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex, UK. gwilson@gci.ac.uk

Acta Oncologica (Stockholm, Sweden)
|February 16, 2002
PubMed
Summary
This summary is machine-generated.

Understanding tumor cell proliferation heterogeneity is key for effective radiotherapy. Measuring this heterogeneity can predict treatment failure and guide chemotherapy and radiotherapy schedules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Rate and Lactate Levels During Weight-Training Exercise in Trained and Untrained Men.

The Physician and sportsmedicine·2016
Same author

Implementation of an electronic data monitoring system decreases the rate of hyperoxic episodes in premature neonates.

Journal of perinatology : official journal of the California Perinatal Association·2013
Same author

Cell kinetic studies using a monoclonal antibody to bromodeoxyuridine.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Cell kinetic studies using a monoclonal antibody to bromodeoxyuridine.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Pulmonary injury after combined exposures to low-dose low-LET radiation and fungal spores.

Radiation research·2011
Same author

New and improved remedial exercise equipment, devised and improvised at Oliver General Hospital, Augusta, Ga.

The Physiotherapy review·2010
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Biology

Background:

  • Current assessment of tumor proliferation has not improved clinical radiotherapy outcomes.
  • Tumor cell proliferation is a critical factor in cancer treatment response.

Purpose of the Study:

  • To present a novel perspective on tumor proliferation and its clinical implications in radiotherapy.
  • To highlight the significance of cell kinetic heterogeneity in predicting radiotherapy and chemotherapy outcomes.

Main Methods:

  • Review of existing literature on tumor cell proliferation and radiotherapy.
  • Discussion of cell kinetic heterogeneity and its measurement.

Main Results:

  • Cell kinetic heterogeneity is a universal characteristic of tumors.

Related Experiment Videos

  • Understanding heterogeneity offers predictive insights into treatment failure patterns.

    • Conclusions:

    • Measuring tumor cell kinetic heterogeneity can guide personalized radiotherapy and chemotherapy schedules.
    • This approach may improve prediction of repopulation and treatment efficacy.